 |
 |

Clinical Practice Guidelines and Scientific Evidence—Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: Dr Norris raises concerns about the process of guideline writing and development by the ACC/AHA. Our study focused on understanding the evolution of classes of recommendation to their present state and, more importantly, the extent to which the various levels of evidence were present within each class of recommendation. In our review, we found nothing to suggest that the ACC/AHA evaluation of evidence results in an inaccurate assessment of the existing evidence base, although this was not a primary objective of our study and was not systematically reviewed. We judged the language used for classes of recommendation and levels of evidence to be appropriate. Given the evolution of changes in the classes of recommendation and levels of evidence ratings of the ACC/AHA, it is our conclusion that the need for recommendations is increasing at a rate much greater than the available evidence base. This situation must be addressed . . . [Full Text of this Article]
Pierluigi Tricoci, MD, MHS, PhD
trico001@dcri.duke.edu
Robert M. Califf, MD
Division of Cardiology Duke Translational Research Institute Durham, North Carolina
Sidney C. Smith Jr, MD
Center for Cardiovascular Science and Medicine University of North Carolina Chapel Hill
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|